Absolute Pro 1012537-60Recalls & reported problems
Abbott Vascular Inc. · Absolute Pro Vascular Self-Expanding Stent System 9.0 mm x 60 mm x 135 cm / Over-The-Wire · Class 3 · Implant
All models of Absolute Pro (51)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648176234), received between Oct 15, 2018 and Feb 13, 2025 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Material Separation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Material Separation3
- Difficult or Delayed Activation2
- Difficult to Advance2
- Activation Failure1
- Material Deformation1
- Mechanical Jam1
- Physical Resistance/Sticking1
- Premature Activation1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Consequences Or Impact To Patient2
- Foreign Body In Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 13, 2025Material Separation; Material Deformation; Mechanical Jam; Activation Failure; Material Separation; Material Deformation; Mechanical Jam; Activation Failure
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A MODERATELY CALCIFIED LESION IN THE LEFT ILIAC ARTERY. A 9X60MM ABSOLUTE PRO SELF-EXPANDING STENT (SES) WAS ADVANCED THROUGH A 6F SHEATH AND OVER A .035X300CM SUPRA CORE GUIDEWIRE TO THE TARGET LESION, WITH NO NOTED RESISTANCE; HOWEVER; DURING DEPLOYMENT THE THUMBWHEEL WAS NOTED TO JAM AND THE STENT COULD ONLY BE PARTIALLY DEPLOYED. THE SES WAS REMOVED THROUGH THE SHEATH AND A NEW NON-ABBOTT STENT WAS DEPLOYED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS NOR CLINICAL DELAY. SUBSEQUENT TO THE INITIALLY REPORTED EVENT, THE DEVICE WAS RECEIVED AND THE RETURNED DEVICE ANALYSIS REVEALED THAT THE STENT SHEATH WAS SEPARATED 2 CM FROM THE DISTAL END OF THE TIP, AND THE DISTAL END OF THE STENT IMPLANT WAS BENT, STRETCHED, AND HAD BROKEN STRUTS. FOLLOW-UP WITH THE ACCOUNT CONFIRMED THAT ALL NOTED DAMAGES FOUND IN THE DEVICE ANALYSIS OCCURRED DURING THE PROCEDURE WHEN THE PORTION OF THE STENT THAT WAS DEPLOYED WAS RE-SHEATHED AND PULLED THROUGH THE 6F SHEATH FOR REMOVAL. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21375992 ↗MalfunctionSep 16, 2024Difficult to Advance; Difficult to Advance
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN AN UNKNOWN VESSEL. REPORTEDLY A 9.0MM X 60MM ABSOLUTE PRO VASCULAR SELF-EXPANDING STENT (SES) WAS PREPARED; HOWEVER, COULD NOT BE ADVANCED OVER THE GUIDEWIRE. THE SES WAS REPLACED WITH ANOTHER ABSOLUTE PRO AND THE PROCEDURE WAS COMPLETED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. RETURNED DEVICE ANALYSIS IDENTIFIED THAT THE JACKET WAS SEPARATED BUT HELD TOGETHER BY THE JACKET MATERIAL. THE ACCOUNT WAS NOT AWARE OF THE DAMAGE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20225455 ↗InjuryMay 4, 2020Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking; Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking
SUBSEQUENT TO FILING THE FINAL MDR, THE FOLLOWING ADDITIONAL INFORMATION WAS RECEIVED: THE CASE WAS A CONTRALATERAL APPROACH. THE SHEATH WAS IN THE LEFT COMMON FEMORAL ARTERY AND THE PHYSICIAN WAS ATTEMPTING TO STENT THE RIGHT ILIAC. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Foreign Body In Patient
MAUDE report 10021068 ↗MalfunctionDec 13, 2018Premature Activation; Difficult to Advance; Premature Activation; Difficult to Advance
IT WAS REPORTED THAT THIS WAS A PERCUTANEOUS INTERVENTION TREATING THE EXTERNAL ILIAC. BEFORE ENTERING INTO THE PATIENT'S ANATOMY, THE ABSOLUTE PRO STENT DELIVERY SYSTEM (SDS) ADVANCED OVER A GUIDE WIRE. REPORTEDLY, FOLLOWING INSERTION, RESISTANCE WAS FELT WHILE ADVANCING THE SDS OVER THE GUIDE WIRE. ONCE AT THE SHEATH AND BEFORE ENTERING THE ANATOMY, THE STENT HAD PREMATURELY DEPLOYED AS STENT FLOWERING WAS OBSERVED. THE DEVICE WAS EASILY REMOVED AND A NON-ABBOTT DEVICE WAS USED IN REPLACEMENT. THERE WERE NO ADVERSE PATIENT EFFECTS AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED REGARDING THIS ISSUE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8160508 ↗MalfunctionOct 15, 2018Material Separation; Difficult or Delayed Activation; Material Separation; Difficult or Delayed Activation
IT WAS REPORTED THAT THE 9.0X60 MM ABSOLUTE PRO STENT WAS ADVANCED TO THE HEAVILY CALCIFIED, RIGHT EXTERNAL ILIAC ARTERY, BUT ONLY PARTIALLY DEPLOYED. THE CATHETERIZATION LAB STAFF DOCUMENTED A FRACTURE ON THE DEVICE, BUT THE PHYSICIAN'S NOTES DID NOT MENTION THIS DEVICE. THE VESSEL WAS TREATED WITH BALLOON DILATATION USING AN 8.0X40 MM ARMADA. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7966031 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Omnilink Elite 1012631-59Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page